Which of the following is listed as a symptom of a hypertensive crisis that can result from MAO inhibitor toxicity?

Correct answer: Severe headache and nuchal rigidity

Explanation

This question requires the identification of specific symptoms associated with hypertensive crisis, a severe adverse effect of MAO inhibitors.

Other questions

Question 1

Besides treating depression, what is another indicated use for the antidepressant bupropion?

Question 2

Which specific antidepressant is mentioned for the treatment of enuresis?

Question 3

What is the most likely general mechanism of action for antidepressants?

Question 4

Which major class of antidepressants is noted to be more likely to cause insomnia?

Question 5

What are the two properties that explain many of the side effects of most tricyclic antidepressants (TCAs)?

Question 6

Which of the following medications is classified as a serotonin/norepinephrine reuptake inhibitor (SNRI)?

Question 7

In which condition are antidepressants explicitly contraindicated, according to the text?

Question 8

What is the typical timeframe for the onset of a therapeutic response to antidepressant medication?

Question 9

What is a potential serious outcome when tricyclic antidepressants (TCAs) are used concurrently with MAO inhibitors?

Question 10

What is the primary risk associated with the concurrent ingestion of MAO inhibitors and tyramine-containing foods?

Question 12

What is the indicated treatment for a hypertensive crisis caused by concurrent ingestion of MAO inhibitors and tyramine-containing foods?

Question 13

What specific patient risk should be assessed for, especially during early antidepressant therapy?

Question 14

According to the implementation guidelines, when should antidepressants that cause sedation be administered?

Question 15

What is the recommended administration time for antidepressants that are known to cause insomnia?

Question 16

What advice should be given to a patient taking antidepressants regarding alcohol and other CNS depressants?

Question 17

For how long does MAO inhibitor therapy typically need to be withdrawn before the use of anesthetic agents for surgery?

Question 18

Which of the following is listed as a desired outcome of antidepressant therapy for children over 6 years of age?

Question 19

Which of the following drug classes does amitriptyline belong to?

Question 20

Which specific antidepressant is indicated for the treatment of bulimia?

Question 21

Why should tricyclic antidepressants be used cautiously in elderly men with prostatic enlargement?

Question 22

What is the primary risk when tricyclic antidepressants are combined with other CNS depressants?

Question 23

What are the potential severe outcomes of combining MAO inhibitors with meperidine or other opioid analgesics?

Question 24

What is the potential interaction when MAO inhibitors are used concurrently with insulin or oral hypoglycemic agents?

Question 25

Which group of antidepressants should not be used in combination with or within weeks of MAO inhibitors?

Question 26

What patient teaching can be provided to diminish the anticholinergic side effect of dry mouth?

Question 27

What is the potential consequence when MAO inhibitors are used concurrently with vasoconstrictors like epinephrine or norepinephrine?

Question 28

Which of the following symptoms is a characteristic sign of a hypertensive crisis that may occur with MAO inhibitor use?

Question 29

Which of the following antidepressants is NOT listed as a treatment for chronic pain syndromes?

Question 30

According to the 'General Use' section, which two antidepressants are listed for the treatment of social anxiety disorder?

Question 31

Antidepressant activity results in the accumulation of which neurotransmitters by preventing their reuptake?

Question 32

Which of the following medications is provided as an example of a tricyclic antidepressant (TCA)?

Question 33

Which of the following medications is listed as a selective serotonin reuptake inhibitor (SSRI)?

Question 34

Which antidepressant is specifically mentioned as having the potential to lower the seizure threshold?

Question 35

What is the result of using tricyclic antidepressants (TCAs) with other drugs that also possess anticholinergic properties?

Question 36

After discontinuing MAO inhibitor therapy, for how long should a patient avoid ingesting tyramine-containing foods or beverages?

Question 37

What is the intended therapeutic effect for the use of antidepressants like doxepin and sertraline in treating anxiety?

Question 38

Which condition is NOT listed as an 'other use' for the antidepressant doxepin?

Question 39

What is the primary characteristic of Selective Serotonin Reuptake Inhibitors (SSRIs) that distinguishes them from Tricyclic Antidepressants (TCAs) in terms of side effects?

Question 40

According to the contraindications, antidepressants should not be used immediately after what medical event?

Question 41

What is the potential risk of using MAO inhibitors with medications like sumatriptan or zolmitriptan?

Question 42

What advice should be given to a patient to help manage constipation that may occur as a side effect of antidepressant therapy?

Question 43

What is the minimum recommended period that MAO inhibitor therapy should be withdrawn before surgery involving anesthetic agents?

Question 44

The medications desvenlafaxine, duloxetine, and venlafaxine belong to which class of antidepressants?

Question 45

What is the potential effect of using tricyclic antidepressants (TCAs) with other sympathomimetic drugs?

Question 46

What is the potential interaction when MAO inhibitors are used with antihypertensives or spinal anesthesia?

Question 47

Which of the following is a primary symptom of a hypertensive crisis caused by MAO inhibitor toxicity?

Question 48

What is a key component of patient teaching regarding the administration of MAOIs and certain foods?

Question 49

What is a listed 'other use' for the antidepressant fluoxetine?

Question 50

According to the text, what is the recommended time frame for the onset of therapeutic response for antidepressants?